CRYSTAL ROWELL: Open Payments
NPI 1477865228 · LUTCHER, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,062 in 23 payments from 12 companies in 2025. Trend: 2023 $890 · 2024 $428 · 2025 $1,062
Food & beverage: $1,062
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 7 | $235 |
| Madrigal Pharmaceuticals | 2 | $170 |
| Dexcom, Inc. | 2 | $152 |
| Novo Nordisk Inc | 2 | $139 |
| Lilly USA, LLC | 2 | $103 |
| Sage Therapeutics, LLC | 1 | $100 |
| ABBVIE INC. | 1 | $63 |
| Currax Pharmaceuticals LLC | 2 | $34 |
| Galderma Laboratories, L.P. | 1 | $22 |
| Lundbeck LLC | 1 | $20 |
Products named: REPATHA, REZDIFFRA, DEXCOM G7 GSS (161), Wegovy, ZEPBOUND, SKYRIZI, OTEZLA, CONTRAVE.
Industry payments across LA — which companies pay providers there.
